Literature DB >> 11353569

Hyperuricemia and renal function.

L M Ruilope1, J Garcia-Puig.   

Abstract

Increased serum urate concentration is commonly seen in clinical practice. It does not represent a specific disease, nor is it an indication for therapy. Hyperuricemia can be the consequence of increased uric acid production and/or decreased renal capacity to excrete uric acid. In essential hypertension, it has been described in up to one third of patients and is directly related to an increase in renal vascular resistance and inversely correlated with renal plasma flow. In other words, abnormal renal hemodynamics, commonly seen in the initial stages of the disease, account for the increased serum urate concentration. This can be maintained if a decrease in glomerular filtration rate takes place. The increase in uric acid has been shown to be a potent predictor of the development of cardiovascular events and death. In addition, uric acid, particularly when elevated, could represent an independent risk factor. On the other hand, an altered renal function predicts in an independent manner a higher cardiovascular risk. For this reason, the predictive capacity of uric acid could be partly dependent on the fact that hyperuricemia runs in parallel with a deranged renal function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353569     DOI: 10.1007/s11906-001-0038-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  60 in total

1.  THE DISTRIBUTION OF SERUM URIC ACID VALUES IN A POPULATION UNSELECTED AS TO GOUT OR HYPERURICEMIA: TECUMSEH, MICHIGAN 1959-1960.

Authors:  W M MIKKELSEN; H J DODGE; H VALKENBURG
Journal:  Am J Med       Date:  1965-08       Impact factor: 4.965

2.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

3.  Identification of the causes of persistent hyperuricaemia.

Authors:  B T Emmerson
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

4.  Female gout. Clinical spectrum and uric acid metabolism.

Authors:  J G Puig; A D Michán; M L Jiménez; C Pérez de Ayala; F A Mateos; C F Capitán; E de Miguel; J B Gijón
Journal:  Arch Intern Med       Date:  1991-04

5.  Serum uric acid and hypertension: the Olivetti heart study.

Authors:  F Jossa; E Farinaro; S Panico; V Krogh; E Celentano; R Galasso; M Mancini; M Trevisan
Journal:  J Hum Hypertens       Date:  1994-09       Impact factor: 3.012

6.  Effect of oestrogen therapy on plasma and urinary levels of uric acid.

Authors:  A Nicholls; M L Snaith; J T Scott
Journal:  Br Med J       Date:  1973-02-24

7.  Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion.

Authors:  A Tykarski
Journal:  Nephron       Date:  1991       Impact factor: 2.847

8.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

Authors:  N B Shulman; C E Ford; W D Hall; M D Blaufox; D Simon; H G Langford; K A Schneider
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

9.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

10.  Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program.

Authors:  H G Langford; M D Blaufox; N O Borhani; J D Curb; A Molteni; K A Schneider; S Pressel
Journal:  Arch Intern Med       Date:  1987-04
View more
  13 in total

1.  Association of incident gout and mortality in dialysis patients.

Authors:  Scott D Cohen; Paul L Kimmel; Robert Neff; Lawrence Agodoa; Kevin C Abbott
Journal:  J Am Soc Nephrol       Date:  2008-05-28       Impact factor: 10.121

Review 2.  Effect of uric-acid-lowering therapy on progression of chronic kidney disease: a meta-analysis.

Authors:  Ye-Fang Zhang; Fan He; Hong-Hui Ding; Wei Dai; Qian Zhang; Hong Luan; Yong-Man Lv; Hong-Bing Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

3.  Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.

Authors:  Fernanda Cristina Mazali; Richard J Johnson; Marilda Mazzali
Journal:  Nephron Exp Nephrol       Date:  2011-11-25

4.  Diagnosis of renal failure disease using Adaptive Neuro-Fuzzy Inference System.

Authors:  Abdurrahim Akgundogdu; Serkan Kurt; Niyazi Kilic; Osman N Ucan; Nilgun Akalin
Journal:  J Med Syst       Date:  2009-05-26       Impact factor: 4.460

5.  Uric acid and the development of metabolic syndrome in women and men.

Authors:  Xuemei Sui; Timothy S Church; Rebecca A Meriwether; Felipe Lobelo; Steven N Blair
Journal:  Metabolism       Date:  2008-06       Impact factor: 8.694

6.  The association between hyperuricemia and the Trp64Arg polymorphism of the beta-3 adrenergic receptor.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2007-01-16       Impact factor: 3.580

7.  The association between shift work and hyperuricemia in steelmaking male workers.

Authors:  Jae-Seok Oh; Won-Jun Choi; Min-Kee Lee; Sung-Woo Han; Seung-Ho Song; Jong-Wan Yun; Sang-Hwan Han
Journal:  Ann Occup Environ Med       Date:  2014-11-04

8.  A four-compartment metabolomics analysis of the liver, muscle, serum, and urine response to polytrauma with hemorrhagic shock following carbohydrate prefeed.

Authors:  Nancy Witowski; Elizabeth Lusczek; Charles Determan; Daniel Lexcen; Kristine Mulier; Beverly Ostrowski; Greg Beilman
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

9.  Noninvasive assessment of the carotid and cerebrovascular atherosclerotic plaques by multidetector CT in type-2 diabetes mellitus patients with transient ischemic attack or stroke.

Authors:  Ci He; Ming Gu; Rui Jiang; Jian-Hao Li
Journal:  Diabetol Metab Syndr       Date:  2013-02-26       Impact factor: 3.320

10.  Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: role of nitric oxide and uric acid.

Authors:  Soha S Essawy; Khaled A Abdel-Sater; Amani A Elbaz
Journal:  Arch Med Sci       Date:  2013-03-06       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.